Select Medical (NYSE:SEM) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPS

Select Medical (NYSE:SEM) released its earnings results on Thursday. The health services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11), Zacks reports. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical updated its FY 2025 guidance to 1.090-1.190 EPS.

Select Medical Stock Performance

NYSE:SEM traded down $0.15 during mid-day trading on Thursday, hitting $19.11. The company’s stock had a trading volume of 975,271 shares, compared to its average volume of 792,814. The business’s fifty day moving average is $19.14 and its two-hundred day moving average is $28.14. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of 8.93, a PEG ratio of 0.64 and a beta of 1.45. Select Medical has a 1 year low of $18.02 and a 1 year high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Insider Activity

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on SEM. StockNews.com downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, February 13th. Royal Bank of Canada lifted their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Finally, UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.